Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Ovarian Neoplasms 3Mesothelioma, Malignant 3Carcinoma, Non-Small-Cell Lung 3Pancreatic Neoplasms 1Non Hematologic Cancers 1Neoplasms, Mesothelial 1Neoplasms 1Neoplasm Metastasis 1Mesothelioma 1Lung Neoplasms 1Low Grade Serous Ovarian Cancer 1Carcinoma, Ovarian Epithelial 1Adenoma 1

Interventions

Carboplatin 367Pemetrexed 308pembrolizumab 302Cisplatin 242Paclitaxel 230Docetaxel 199Gemcitabine 130Nivolumab 121Erlotinib Hydrochloride 114Bevacizumab 85osimertinib 78atezolizumab 65durvalumab 58Cetuximab 57130-nm albumin-bound paclitaxel 56Gefitinib 52Ipilimumab 46Afatinib 38Drug Therapy 33Cyclophosphamide 30Crizotinib 30Albumin-Bound Paclitaxel 30Vinorelbine 28cemiplimab 26tislelizumab 25avelumab 23icotinib 22Radiotherapy 22capmatinib 21Oxaliplatin 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Carcinoma, Non-Small-Cell Lung × defactinib × Clear all
NCT05074810 2026-01-12

RAMP203

Verastem, Inc.

Phase 1/2 Active not recruiting
153 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04620330 2024-01-12

RAMP202

Verastem, Inc.

Phase 2 Completed
90 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01951690 2017-04-13

Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer

Verastem, Inc.

Phase 2 Completed
55 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡